Saratov JOURNAL of Medical and Scientific Research

Bacterial collagenase in the treatment of vitreoretinal pathology

Year: 2018, volume 14 Issue: №4 Pages: 953-956
Heading: Ophtalmology Article type: Review
Authors: Zgoba M.l., Lyskin P.V., Makarenko I.R.
Organization: The S. Fyodorov Eye Microsurgery Federal State Institution

Bacterial collagenase has been used in Russian ophthalmology for more than 40 years, its official medical use is allowed since 1983 Collagenase is used in the treatment of a broad spectrum of ophthalmopathology For the treatment of vitreoretinal pathology the drug has been used since 1996 To date, quite a lot of experience in the use of bacterial collagenase for the treatment of vitreoretinal pathology has been accumulated. The article presents the literature data on the possibilities of using the drug in various areas of vitreoretinal pathology and the prospects of expanding the indications for the use of the drug in a wider ophthalmic practice.

1 Danilichev VF. Prevention and treatment of post-burn simblefaron: PhD abstract. L, 1983; 18 p.
2 Prikaz Minzdrava SSSR ot 04.08.1983 №914 «О razreshenii k medicinskomu primeneniju novyh lekarstvennyh sredstv, i standartov, primenjaemyh pri analize lekarstvennogo sredstv». M., 1983
3 Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. Engl J Med 2009; 361 (10): 968-79
4 O'Neill R, Shea M. The effects of bacterial collagenase in rabbit vitreous. Can J Ophthalmol 1973; 8 (2): 366-70
5 Danilichev VF. Eye pathology enzymes and inhibitors. Spb.: Stroipechat, 1996, 235 p.
6 Tustanovskij АА. The problem of the relationship between procollagen and collagen components in fibrillogenesis. Arh patol1960; (3): 3-12
7 Tustanovskij АА. Contradictions of the modern stage of studying the development of collagen proteins and collagen structures. In: Mehanizmy skleroticheskih processov i rubcevanie. Novosibirsk, 1964; 13-32 p.
8 Tustanovskij АА, Cellarius JuG. Connective tissue in health and disease. Novosibirsk, 1968; 415 p.
9 Morozov VI, Krasavina BS, Zolotov SN, et al. The first experience of using collagenase in diseases of the cornea. The Russian Annals of Ophthalmology 1972; (1): 47-50
10 Kugleev АА. Treatment of patients with bleeding in the vitreous body and effects of electrophoresis with collision. In: 4-j Vserossijskij sjezd oftalmologov: tez dokl. L, 1981; 1: 15-16
11 Polunin GS. Indications and methods of enzyme therapy in ophthalmic practice: DSc abstract. Moscow, 1990; 15 p.
12 Lyskin PV, Pismenskaya VA. Intraoperative use of collalizin in surgical treatment of vitreoretinal pathology. Ophthalmosurgery 2001; (4): 38-42
13 Lyskin PV. Uncirculated tactics of retinal detachment surgical treatment. Ophthalmosurgery 2002; (2): 24-7
14 Zapuskalov IV, Nazarenko КА, Berezovskaya АА. Our experience in the treatment of proliferative diabetic retinopathy with the use of kollalizin (clinical cases). Ophthalmosurgery 2006; (2): 37-40
15 Method of carrying out enzyme: patent №2303457 (RF) / I.V Zapuskalov, K.A. Nazarenko. Bull. 2007; (21): 8
16 Takhchidi KhP, Lyskin PV, Lozinskaya OL, et al. Enzyme-Assisted Vitrectomy for Treatment of Idiopathic Macular Holes. Ophthalmosurgery 2010; (1): 19-24
17 Shishkin MM, Yuldasheva NM, Antonyuk SV. Clinic & morphological changes of intraocular structures in intravitreal kollalisin injection in the experiment. Russian Ophthalmological Journal 2010; (4): 54-9
18 Pismenskaya VA. Application of collagenase in surgical treatment of retinal detachment complicated by proliferative vitreoretinopathy: PhD abstract. Moscow, 2016; 22 p.
19 Lyskin PV, Zaharov VD, ShpakAA, et al. Microinvasive treatment of vitreomacular traction. Current Problems of Ophthalmology 2018; (1): 236-7.

2018_4-2_953-956_1.pdf267.8 KB

No votes yet